Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.5266
-0.1674
(-24.12%)
At close: December 2 at 4:00:00 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BREITMEYER JAMES B Chief Executive Officer | Purchase | Apr 14, 2023 | -- |
| HALE DAVID F Director | Purchase | Feb 23, 2024 | -- |
| KAUFMANN GUNNAR F Officer | Purchase | Jun 14, 2023 | 94,726 |
| LEAVITT CHASE C. General Counsel | Purchase | Apr 13, 2023 | 106,901 |
| VINCENT RICHARD G. Chief Financial Officer | Purchase | Apr 13, 2023 | 163,219 |
| WILLS ROBERT JAMES Director | Purchase | Apr 8, 2024 | 10,000 |
| YAZJI SALIM M.D. Officer | Purchase | Apr 14, 2023 | 164,676 |
Related Tickers
HQ1.MU Oruka Therapeutics Inc. R
9.45
-7.35%
SPRB Spruce Biosciences, Inc.
0.3890
+2.64%
POLB.L Poolbeg Pharma PLC
3.4500
-2.82%
C4X.F Valerio Therapeutics Société anonyme
0.0520
+1.76%
2616.HK CStone Pharmaceuticals
3.430
-8.29%
OMY.SG Synairgen plc
0.0115
0.00%
ARDX.MX Ardelyx, Inc.
105.50
0.00%
MOC.WA Molecure S.A.
8.98
-0.11%
MAGLE.ST Magle Chemoswed Holding AB (publ)
31.20
+0.65%
NV3P.F NanoViricides, Inc.
1.2100
+2.54%